LEI 81560071315E869F7028

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Awards tracked

52

Value

€15.52M

Countries

IT

Download sample CSV

Contract awards & public grants

Training a New Generation to Decode the Human Cis-Regulatory Genome → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2026-07-10

€281,755

Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase. → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2026-06-11

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-11-03

€300,000

101218845 - UNIFIED - UNIFYING FRAMEWORK FOR PATIENT-CENTRED CLINICAL-STUDY ENDPOINTS DERIVED FROM DIGITAL HEALTH TECHNOLOGIES → ISTITUTO EUROPEO DI ONCOLOGIA SRL

IMI - Innov.Health Initiative · IT · Grant · 2025-11-01

€300,006

A training network on glyconanomaterials as precision tools to unveil key insights on the triggering of the antigen presenting cells against cancer → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-06-30

—

UNCAN-CONNECT: Decentralized Collaborative Network for Advancing Cancer Research and Innovation → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-05-16

€450,000

Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-05-14

€315,000

Exploring silencer functions via their associated chromatin factors → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-05-02

€209,483

Understanding Nanoparticle Transport Mechanisms in the Melanoma Microenvironment via a Tumor-on-a-Chip Approach → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-04-10

—

Development and validation of a pan-cancer neutrophil biomarker test for predicting clinical benefit from immunotherapy based on flow cytometry analys → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-03-24

€415,000

iINGUT: immunotherapy on an INtegrated GUt microbiome and Tumor on-chip. → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2025-02-27

€193,643

101161236 - ALTHEA - TACKLING MENTAL HEALTH CANCER PATIENTS AND THEIR FAMILIES: DIGITAL SOLUTIONS FOR BETTER CARE → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2024-09-01

€801,035

METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2024-06-25

—

Patient-specific Microstructural and radIobiological model for persoNalised external beam radiatIONn therapy in localised tumourS → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2024-04-15

—

Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2023-12-11

€283,125

IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION: AN INTEGRATED PLATFORM TO PROMOTE BEHAVIOURAL CHA → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2023-12-11

€1.13M

Targeting the Polycomb Machinery in BAP1-related Pathologies → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2023-12-06

€150,000

101129375 - INTERACT-EUROPE 100 - INTERACT-EUROPE 100 → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2023-12-01

€17,976

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2023-04-24

—

Impact of cell shapes on cell behaviour and fate → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2023-03-06

—

101101261 - TRANSITION - DIGITAL TRANSITION AND DIGITAL RESILIENCE IN ONCOLOGY → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2023-03-01

€50,932

101080048 - SMARTCARE - SMART CARD APPLICATION IMPROVING CANCER SURVIVORS QUALITY OF LIFE → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2023-01-01

€5,992

101079984 - PCM4EU - PERSONALISED CANCER MEDICINE FOR ALL EU CITIZENS → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2023-01-01

€128,314

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2022-12-02

€703,900

101080005 - BEACON - CANCER CARE BEACON - REDUCING DISPARITIES ACROSS THE EUROPEAN UNION → ISTITUTO EUROPEO DI ONCOLOGIA SRL

HADEA - European Health and Digital Executive Agency · IT · Grant · 2022-11-01

€415,133

Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2022-05-23

€400,875

European Cohorts of Patients and Schools to Advance Response to Epidemics → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2021-11-15

€540,269

Optimal treatment for patients with solid tumours in Europe through Artificial intelligence → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2021-10-18

€50,000

EGFR signalling talks to mitochondria through contact sites → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2021-06-14

€920,063

AN INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF THE ELDERLY MULTIMORBID PATIENT WITH BREAST CANCER THERAPY INDUCED CARDIAC TOXICITY → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2021-01-22

€519,000

Deacetylase inhibitors for autism spectrum disorders: an integrated preclinical validation pipeline in brain organoids and in vivo models → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2020-06-10

€41,655

NGS diagnostics in 21st century oncology: the best, for all, at all times → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2019-12-13

—

METROFOOD-RI Preparatory Phase Project → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2019-11-20

—

Molecular basis of human enhanceropathies → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2019-08-09

€261,500

European Proteomics Infrastructure Consortium providing Access → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2018-12-03

€488,125

Chromatin architecture and Design → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2018-08-20

€261,500

AuTonomous intraLuminAl Surgery → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2018-08-17

—

EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2017-12-08

€211,693

Immuno-targeting of human AML quiescent cells by a novel phage display approach. → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2017-10-31

€150,000

Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2017-10-16

€385,600

Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2017-06-20

€1.17M

A Systems medicine approach to chronic inflammatory disease → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2016-12-01

€396,954

SMart weArable Robotic Teleoperated Surgery → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2016-11-29

€127,500

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2016-10-21

€496,750

The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2016-07-27

€1.38M

Leading Innovative measures to reach gender Balance in Research Activities → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2015-06-15

€218,938

Training Network for the Immunotherapy of Cancer → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2015-06-12

€143,367

Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2015-04-07

€489,000

Female cancer prediction using cervical omics to individualise screening and prevention → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2015-03-27

€160,500

Chromatin Dynamics in Development and Disease → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2014-12-12

€93,189

iManageCancer - Empowering patients and strengthening self-management in cancer diseases → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2014-12-08

€464,150

European Consortium for Communicating Stem Cell Research → ISTITUTO EUROPEO DI ONCOLOGIA SRL

European Commission · IT · Grant · 2014-12-01

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.